These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1969431)
1. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. Czerniak B; Herz F; Wersto RP; Alster P; Puszkin E; Schwarz E; Koss LG J Histochem Cytochem; 1990 Apr; 38(4):463-6. PubMed ID: 1969431 [TBL] [Abstract][Full Text] [Related]
2. Asymmetric distribution of oncogene products at mitosis. Czerniak B; Herz F; Wersto RP; Koss LG Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4860-3. PubMed ID: 1350677 [TBL] [Abstract][Full Text] [Related]
3. Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology. Saccani Jotti G; Fontanesi M; Bombardieri E; Gabrielli M; Veronesi P; Bianchi M; Becchi G; Bogni A; Tardini A Int J Biol Markers; 1992; 7(1):35-42. PubMed ID: 1349907 [TBL] [Abstract][Full Text] [Related]
4. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma. Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998 [TBL] [Abstract][Full Text] [Related]
5. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer. Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023 [TBL] [Abstract][Full Text] [Related]
6. Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cells. Benz CC; Scott GK; Santos GF; Smith HS J Natl Cancer Inst; 1989 Nov; 81(22):1704-9. PubMed ID: 2572702 [TBL] [Abstract][Full Text] [Related]
7. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry. Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas. Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689 [TBL] [Abstract][Full Text] [Related]
9. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues. Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical study of ras and myc proto-oncogene polypeptide expression in the human menstrual cycle. Odom LD; Barrett JM; Pantazis CG; Stoddard LD; McDonough PG Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1663-8. PubMed ID: 2690632 [TBL] [Abstract][Full Text] [Related]
11. Comparison of EGFR, c-erbB-2 product and ras p21 immunohistochemistry as prognostic markers in primary breast cancer. Hainsworth PJ; Henderson MA; Stillwell RG; Bennett RC Eur J Surg Oncol; 1991 Feb; 17(1):9-15. PubMed ID: 1671658 [TBL] [Abstract][Full Text] [Related]
12. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689 [TBL] [Abstract][Full Text] [Related]
13. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Pääkkö P; Nuorva K; Kamel D; Soini Y Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655 [TBL] [Abstract][Full Text] [Related]
14. [Experimental study of the expression of c-myc, c-fos and proto-oncogenes on hypertrophic and scars]. Hu Z; Lou L; Luo S Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 May; 18(3):165-7. PubMed ID: 12189705 [TBL] [Abstract][Full Text] [Related]
15. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Volm M; Mattern J Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109 [TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas. Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035 [TBL] [Abstract][Full Text] [Related]
17. c-myc oncogene product expression and prognosis in operable breast cancer. Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW; Sikora K; Evan G; Robins RA Br J Cancer; 1989 Nov; 60(5):669-72. PubMed ID: 2679850 [TBL] [Abstract][Full Text] [Related]
18. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry. Li BD; Bauer KD; Carney WP; Duda RB J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635 [TBL] [Abstract][Full Text] [Related]
19. [Immunohistological study on ras and myc oncogene products in pancreatic cancer]. Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243 [TBL] [Abstract][Full Text] [Related]
20. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Volm M; Efferth T; Mattern J Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]